HOP Claude Huriez

Lille 59037

0 studies enrolling now · 3 studies all time

What they study most

Lung Diseases, Interstitial, Non-alcoholic Fatty Liver Disease, Scleroderma, Systemic

Studies at this site

• A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis — Completed
• Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH — Completed
• A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis — Completed